Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.22%

Gilead Sciences Inc. (GILD)

-NasdaqGS
112.85 Up 0.39(0.35%) May 28, 4:00PM EDT
|After Hours : 112.90 Up 0.05 (0.04%) May 28, 7:58PM EDT
Add to Portfolio
Prev Close:112.46
Open:112.01
Bid:112.78 x 1500
Ask:112.97 x 400
1y Target Est:121.22
Beta:0.93
Earnings Date:Jul 21 - Jul 27 (Est.)
Day's Range:111.82 - 113.43
52wk Range:78.50 - 116.83
Volume:8,252,431
Avg Vol (3m):11,071,000
Market Cap:166.68B
P/E (ttm):12.87
EPS (ttm):8.77
Div & Yield:1.72 (1.70%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
GILDUp 0.35%166.68B
GSKUp 0.40%108.17B
PFEUp 0.41%212.07B
RHHBYUp 1.38%N/A

Key Statistics

Forward P/E (1 yr):10.24
P/S (ttm):6.01
Ex-Dividend Date:12-Jun-15

Analysts

Annual EPS Est (Dec-15) :10.86
Quarterly EPS Est (Jun-15) :2.66
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback